Replies to post #7863 on Algernon Pharmaceuticals Inc (AGNPF)

[boomer0921]

if you think a 1 for 10 is likely down the road

IMVHO, I really do not see that happening for where this is going, should they get any indication this will help chronic cough, let alone lung functionability or Covid. LOL>

[Money $hot]

Q&A session:

Lucky

I'm confused but I dont know much. Why would an investor accumulate stock if as you say a reverse split is inevitable? The previous 1 for 2 was devastating and if you think a 1 for 10 is likely down the road it just seems a slippery uphill battle trying to accumulate a reasonable position of shares.
© 2020 InvestorsHub.com, Inc.

AMG

IMO, an uplisting (if/when) should come without a necessary stock split. Therefore, Algernon should move forward as is until such time a multiple dollar stock is realized. As of this exact moment you would be looking at a minimum 1 for 10 reverse split. Nobody wants that.

What I mean is at the current share price in the USD 0.30 cent range, an uplisting to say NASDAQ would require a stock price of $3 or more. That's my understanding of minimum requirements for a NASDAQ uplisting. Now I could be wrong, but the point is to get to $3 per share would require a reverse split of 1 for 10. What I'm saying is uplisting is premature. Let's simply get out of the friggin pennies and see what happens next. Personally, I don't think an uplisting will be necessary. If/when positive trial data comes through Algernon will be a Big Pharma buyout target - if not already.

According to management, the lines are ringing off the hook at corporate!

By all indications the incentive is to accumulate shares.

Just 1 opinion,

/////AMG

$AGNPF

[medchem]

Refer to the BioPub interviews which are public. The CEO said they have enough funding.